Press release
Rising Cancer Prevalence Fuels Growth In The Sorafenib Market An Overview Of Current Trends And Future Projections: Major Factor in the Transformation of the Sorafenib Market in 2025
Sorafenib Market Share
The market size of sorafenib has been showing consistent expansion over recent years. Growth is anticipated to go from $1.24 billion in 2024 onwards to $1.3 billion in 2025, registering a compound annual growth rate (CAGR) of 4.4%. The notable growth during the historic timeframe can be credited to supportive government policies, growth in reimbursement programs, an increase in authorizations for fresh pharmaceuticals, an escalation in apoptosis within carcinoma cells, an augmented occurrence of target cancers, and the surge in research studies focusing on sorafenib.
Anticipations are for the sorafenib market size to experience consistent expansion over the next several years. Its growth is projected to reach $1.53 billion by 2029, with a compound annual growth rate (CAGR) of 4.2%. Factors contributing to this growth within the forecast period include a surge in thyroid cancer cases, rise in overall cancer diagnoses, burgeoning prevalence of chronic illnesses, an intensified focus on precision medicine, and an uptick in incidences of both liver and renal cancers. Key trends to watch during this forecast period are progress in early detection and treatment, developments in alternative treatment options, advancements in hepatocellular carcinoma (HCC), technological evolution in drug delivery methods, and progress in renal cell carcinoma treatment.
What Key Elements Are Boosting Growth in the Sorafenib Market?
The sorafenib market is poised for expansion due to the escalating incidence of cancer. Cancer is characterized by uncontrolled growth and division of abnormal cells, which have the capacity to infiltrate and damage healthy tissue in the body. The spike in cancer cases is attributed to various factors such as aging populations, lifestyle habits, environmental factors, and progression in diagnostic methods that lead to increased detection of cases. Sorafenib, a multi-kinase inhibitor, is integral to cancer treatment as it targets principal signaling routes involved in tumor growth and angiogenesis. It serves as an efficacious treatment for patients suffering from advanced renal cell carcinoma and hepatocellular carcinoma. For example, data from the National Center for Biotechnology Information, a US-based intergovernmental organization, revealed that approximately 1,958,310 new cancer cases and 609,820 cancer fatalities were reported in 2023. Consequently, the rising incidence of cancer is fuelling the expansion of the sorafenib market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19199&type=smp
Who Are the Major Industry Players Fueling Sorafenib Market Expansion?
Major companies operating in the sorafenib market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Novartis AG, Bristol Myers Squibb , Mylan N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Amgen Inc., Cipla Limited, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Exelixis Inc., Natco Pharma, Beacon Pharmaceuticals Ltd., Hetero Healthcare Ltd., Aprazer Healthcare Private Limited, Wellona Pharma, Anant Pharmaceuticals Pvt. Ltd., Intelicure Lifescience
Which Key Developments Are Influencing the Sorafenib Market?
Leading firms in the sorafenib market are concentrating on the creation of innovative offerings, including cost-effective generic versions of sorafenib tablets, to amplify effectiveness and patient adherence while catering to distinct requirements in cancer care. Economical generics deliver comparable curative effects as their branded counterparts but at a notably lesser cost. Such medications assist in minimizing the expenses related to healthcare while retaining equivalent clinical effectiveness as the branded versions. For example, in June 2022, Dr. Reddy's Laboratories, a pharmaceutical manufacturing firm in India, introduced generic Sorafenib tablets for treating different types of cancer in the US market, with the approval from the US Food and Drug Administration (USFDA). This medication is a generic alternative to Bayer's Nexavar, useful in the treatment of several cancers, including liver, kidney, and thyroid. The Sorafenib tablets are accessible in 200 mg fractions and are supplied in bottles of 120 tablets.
How Is the Segmentation of the Sorafenib Market Defined?
The sorafenibmarket covered in this report is segmented -
1) By Product: Patented Drugs, Generic Drugs
2) By Distribution Channel: Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies
3) By Application: Kidney Cancer, Liver Cancer, Thyroid Cancer
Subsegments:
1) By Patented Drugs: Nexavar
2) By Generic Drugs: Generic Sorafenib Tosylate, Other Generic Variants
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/sorafenib-global-market-report
What Is the Leading Region in the Sorafenib Market?
North America was the largest region in the sorafenib market in 2024. The regions covered in the sorafenib market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Sorafenib Global Market Report?
- Market Size Analysis: Analyze the Sorafenib Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Sorafenib Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Sorafenib Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Sorafenib Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19199
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Cancer Prevalence Fuels Growth In The Sorafenib Market An Overview Of Current Trends And Future Projections: Major Factor in the Transformation of the Sorafenib Market in 2025 here
News-ID: 3871788 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Sorafenib
Sorafenib Tosylate Tablets Market to Observe Strong Development by 2030
Global Sorafenib Tosylate Tablets Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis
Sorafenib Tosylate Tablets Market Overview
The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Sorafenib Tosylate Tablets Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as…
Global Sorafenib Market Research Report
This report studies the global Sorafenib market status and forecast, categorizes the global Sorafenib market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Allergan Alnylam Pharmaceuticals Acceleron Pharma Biocon Bionomics CASI Pharmaceuticals Celgene Corporation Enzon Pharmaceuticals Five Prime Therapeutics Fujifilm Kyowa…
Sorafenib Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-pharmaceuticals/sorafenib-market/71807
The global market size of Sorafenib is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.
There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.
For geography segment, regional supply, application-wise and type-wise demand, major…
EMEA Sorafenib Market Research Report 2018- QY Research, Inc.
In this report, the EMEA Sorafenib market is valued at USD million in 2017 and is expected to reach USD million by the end of 2025, growing at a CAGR of % between 2017 and 2025.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Sorafenib for these regions, from 2013 to 2025 (forecast)
…
Global Sorafenib Sales Market Report 2017
Report Hive Market Research Released a New Research Report of 119 pages on Title " Global Sorafenib Sales Market Report 2017 "with detailed Analysis, Forecast and Strategies.
Sorafenib (co-created and co-advertised by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor tranquilize endorsed for the treatment of essential kidney tumor (progressed renal cell carcinoma), propelled essential liver growth (hepatocellular carcinoma), and radioactive iodine safe propelled thyroid carcinoma.
In this report, the…
Global Sorafenib Market Size, Share, Trends and Forecast 2017
Market Research Hub includes new market research report "Global Sorafenib Market Research Report 2017" to its huge collection of research reports. In this report, the global Sorafenib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Request Free Sample Report - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1128597
Geographically, this report is segmented into several…
